Thanks!!
๏ปฟOn 12/14/20, 10:04 AM, "Antibody Discussion Forum on behalf of
<email obscured>" <email obscured> on behalf of <email obscured>>
wrote:
WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
Laura try this
ABRF President is inviting you to a scheduled Zoom meeting.
Join Zoom Meeting
https://urldefense.com/v3/__https://us02web.zoom.us/w/85805245201?tk=r_0_Cv4nSnq5uMtw5exaqoyTzZO5l9U5iOrrh-ECako.DQIAAAAT-mQjERZYN05uMEZmRFFHV2lsZ3RQdlZzcTNnAAAAAAAAAAAAAAAAAAAAAAAAAAAA&pwd=cElET3hYZHlzdVpaU2VJUGI2bm13dz09__;!!PfbeBCCAmug!yc4EA8nAxVBpAMiuItVOw4Kq79_fftZtmYXz0odKC1IcMDX_aTokQTGAb1e6iGF4$
Meeting ID: 858 0524 5201
Passcode: 033875
One tap mobile
+16465588656,,85805245201#,,,,,,0#,,033875# US (New York)
+13126266799,,85805245201#,,,,,,0#,,033875# US (Chicago)
Dial by your location
+1 646 558 8656 US (New York)
+1 312 626 6799 US (Chicago)
+1 301 715 8592 US (Washington D.C)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
Meeting ID: 858 0524 5201
Passcode: 033875
Find your local number:
https://urldefense.com/v3/__https://us02web.zoom.us/u/kyEnPMjKr__;!!PfbeBCCAmug!yc4EA8nAxVBpAMiuItVOw4Kq79_fftZtmYXz0odKC1IcMDX_aTokQTGAb3I-PsKa$
Frances
ZRC 1563
Office 646-888-2354
Mobile 516-967-0656
On 12/14/20, 10:17 AM, "Antibody Discussion Forum on behalf of Bover,Laura"
<email obscured> on behalf of <email obscured>> wrote:
Hi David I registered already. How will we access the webinar?
Laura Bover, PhD
(working from home during COVID-19 Cell 713-703-1951<tel:713-703-1951>)
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of
Biomedical Sciences at Houston
Member of the Scientific Review Committee 2 (former Clinical Research
Committee 2)
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://2/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://3/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
In order to continue obtaining Core support in a challenging
environment, it is crucial that our users acknowledge the following grants in
all publications (see following text). Thank you!
โWe acknowledge the UT-MDACC Monoclonal Antibodies Core facility,
supported in part by CCSG grant number P30 CA016672.โ
Sent from my iPhone
On Dec 14, 2020, at 8:16 AM, David Blum <email obscured>> wrote:
WARNING: This email originated from outside of MD Anderson. Please
validate the sender's email address before clicking on links or attachments as
they may not be safe.
There is still time to register for the webinar this morning at 11am.
We
are also looking for speakers for next year. Please contact me if you
would like to speak or are willing to invite a speaker.
Antibody Technology Interest Network Presentation:
The Link between T Follicular Helper Responses and Neutralizing
Antibody
and Memory B Cell Responses to SARS-CoV-2
Monday, December 14, 2020 11:00 a.m.โ12:00 p.m. ET
Register here
<https://urldefense.com/v3/__https://us02web.zoom.us/meeting/register/tZEld-yqqj4oGtVYWVL_exfgItEG-6GfKrMo__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdNdX2W2j$
>
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5Qd6hb0c9gVeAVYxISQQOf__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdPVsr1nx$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/7v0YX5vmhZUVMBr2rCj3b9__;!!PfbeBCCAmug!yc4EA8nAxVBpAMiuItVOw4Kq79_fftZtmYXz0odKC1IcMDX_aTokQTGAb4SoHVnN$
Leave group <email obscured>?Subject=Unsubscribe
*** Only open attachments or links from trusted senders. Report
phishing to <email obscured> ***
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged,
confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this
message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/1S4VfSISA18F9VBHkv1w3i__;!!PfbeBCCAmug!yc4EA8nAxVBpAMiuItVOw4Kq79_fftZtmYXz0odKC1IcMDX_aTokQTGAb9RPrft7$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
Laura try this
ABRF President is inviting you to a scheduled Zoom meeting.
Join Zoom Meeting
https://us02web.zoom.us/w/85805245201?tk=r_0_Cv4nSnq5uMtw5exaqoyTzZO5l9U5iOrrh-ECako.DQIAAAAT-mQjERZYN05uMEZmRFFHV2lsZ3RQdlZzcTNnAAAAAAAAAAAAAAAAAAAAAAAAAAAA&pwd=cElET3hYZHlzdVpaU2VJUGI2bm13dz09
Meeting ID: 858 0524 5201
Passcode: 033875
One tap mobile
+16465588656,,85805245201#,,,,,,0#,,033875# US (New York)
+13126266799,,85805245201#,,,,,,0#,,033875# US (Chicago)
Dial by your location
+1 646 558 8656 US (New York)
+1 312 626 6799 US (Chicago)
+1 301 715 8592 US (Washington D.C)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
Meeting ID: 858 0524 5201
Passcode: 033875
Find your local number: https://us02web.zoom.us/u/kyEnPMjKr
Frances
ZRC 1563
Office 646-888-2354
Mobile 516-967-0656
๏ปฟOn 12/14/20, 10:17 AM, "Antibody Discussion Forum on behalf of Bover,Laura"
<email obscured> on behalf of <email obscured>> wrote:
Hi David I registered already. How will we access the webinar?
Laura Bover, PhD
(working from home during COVID-19 Cell 713-703-1951<tel:713-703-1951>)
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Scientific Review Committee 2 (former Clinical Research
Committee 2)
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://2/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://3/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
In order to continue obtaining Core support in a challenging environment,
it is crucial that our users acknowledge the following grants in all
publications (see following text). Thank you!
โWe acknowledge the UT-MDACC Monoclonal Antibodies Core facility,
supported in part by CCSG grant number P30 CA016672.โ
Sent from my iPhone
On Dec 14, 2020, at 8:16 AM, David Blum <email obscured>> wrote:
WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
There is still time to register for the webinar this morning at 11am. We
are also looking for speakers for next year. Please contact me if you
would like to speak or are willing to invite a speaker.
Antibody Technology Interest Network Presentation:
The Link between T Follicular Helper Responses and Neutralizing Antibody
and Memory B Cell Responses to SARS-CoV-2
Monday, December 14, 2020 11:00 a.m.โ12:00 p.m. ET
Register here
<https://urldefense.com/v3/__https://us02web.zoom.us/meeting/register/tZEld-yqqj4oGtVYWVL_exfgItEG-6GfKrMo__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdNdX2W2j$
>
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5Qd6hb0c9gVeAVYxISQQOf__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdPVsr1nx$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
โโ
View topic http://list.abrf.org/r/topic/7v0YX5vmhZUVMBr2rCj3b9
Leave group <email obscured>?Subject=Unsubscribe
*** Only open attachments or links from trusted senders. Report phishing to
<email obscured> ***
Rest of post
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
Laura,
You should receive the info for the webinar after you register.
Rest of post
On Mon, Dec 14, 2020 at 10:17 AM Bover,Laura <email obscured>> wrote:
> Hi David I registered already. How will we access the webinar?
>
> Laura Bover, PhD
> (working from home during COVID-19 Cell 713-703-1951<tel:713-703-1951>)
> Professor
> Director Monoclonal Antibody Core Facility
> University of Texas M.D.Anderson Cancer Center
> Associate member of The University of Texas Graduate School of Biomedical
> Sciences at Houston
> Member of the Scientific Review Committee 2 (former Clinical Research
> Committee 2)
> Member of the Steering Committee of the Immunology Program GSBS
> Immunology Department/ Genomics Medicine Department
> 7455 Fannin St<x-apple-data-detectors://2/1> Room 1SCR4.2021
> Houston- TX 77054<x-apple-data-detectors://3/0>
> T 713-563-3301<tel:713-563-3301>
> F 713-563-3276<tel:713-563-3276>
> <email obscured><email obscured>>
>
> In order to continue obtaining Core support in a challenging environment,
> it is crucial that our users acknowledge the following grants in all
> publications (see following text). Thank you!
> โWe acknowledge the UT-MDACC Monoclonal Antibodies Core facility,
> supported in part by CCSG grant number P30 CA016672.โ
>
> Sent from my iPhone
>
> On Dec 14, 2020, at 8:16 AM, David Blum <email obscured>> wrote:
>
> ๏ปฟWARNING: This email originated from outside of MD Anderson. Please
> validate the sender's email address before clicking on links or attachments
> as they may not be safe.
>
> There is still time to register for the webinar this morning at 11am. We
> are also looking for speakers for next year. Please contact me if you
> would like to speak or are willing to invite a speaker.
>
> Antibody Technology Interest Network Presentation:
> The Link between T Follicular Helper Responses and Neutralizing Antibody
> and Memory B Cell Responses to SARS-CoV-2
> Monday, December 14, 2020 11:00 a.m.โ12:00 p.m. ET
>
> Register here
> <
>
https://urldefense.com/v3/__https://us02web.zoom.us/meeting/register/tZEld-yqqj4oGtVYWVL_exfgItEG-6GfKrMo__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdNdX2W2j$
> >
>
> โโ
> View topic
>
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5Qd6hb0c9gVeAVYxISQQOf__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdPVsr1nx$
> Leave group <email obscured>?Subject=Unsubscribe
>
> The information contained in this e-mail message may be privileged,
> confidential, and/or protected from disclosure. This e-mail message may
> contain protected health information (PHI); dissemination of PHI should
> comply with applicable federal and state laws. If you are not the intended
> recipient, or an authorized representative of the intended recipient, any
> further review, disclosure, use, dissemination, distribution, or copying of
> this message or any attachment (or the information contained therein) is
> strictly prohibited. If you think that you have received this e-mail
> message in error, please notify the sender by return e-mail and delete all
> references to it and its contents from your systems.
>
> โโ
> View topic http://list.abrf.org/r/topic/7v0YX5vmhZUVMBr2rCj3b9
> Leave group <email obscured>?Subject=Unsubscribe
>
>
Hi David I registered already. How will we access the webinar?
Laura Bover, PhD
(working from home during COVID-19 Cell 713-703-1951<tel:713-703-1951>)
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Scientific Review Committee 2 (former Clinical Research Committee
2)
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://2/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://3/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
In order to continue obtaining Core support in a challenging environment, it is
crucial that our users acknowledge the following grants in all publications
(see following text). Thank you!
โWe acknowledge the UT-MDACC Monoclonal Antibodies Core facility, supported in
part by CCSG grant number P30 CA016672.โ
Sent from my iPhone
On Dec 14, 2020, at 8:16 AM, David Blum <email obscured>> wrote:
๏ปฟWARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
There is still time to register for the webinar this morning at 11am. We
are also looking for speakers for next year. Please contact me if you
would like to speak or are willing to invite a speaker.
Antibody Technology Interest Network Presentation:
The Link between T Follicular Helper Responses and Neutralizing Antibody
and Memory B Cell Responses to SARS-CoV-2
Monday, December 14, 2020 11:00 a.m.โ12:00 p.m. ET
Register here
<https://urldefense.com/v3/__https://us02web.zoom.us/meeting/register/tZEld-yqqj4oGtVYWVL_exfgItEG-6GfKrMo__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdNdX2W2j$
>
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5Qd6hb0c9gVeAVYxISQQOf__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdPVsr1nx$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
There is still time to register for the webinar this morning at 11am. We
are also looking for speakers for next year. Please contact me if you
would like to speak or are willing to invite a speaker.
Antibody Technology Interest Network Presentation:
The Link between T Follicular Helper Responses and Neutralizing Antibody
and Memory B Cell Responses to SARS-CoV-2
Monday, December 14, 2020 11:00 a.m.โ12:00 p.m. ET
Register here
<https://us02web.zoom.us/meeting/register/tZEld-yqqj4oGtVYWVL_exfgItEG-6GfKrMo>
Dear All,
I have a non-profit customer that would like to have polyclonal antibodies made
in New Zealand white rabbits and purified. The antigen has been used
successfully in the past, and the polyclonal antibodies produced have been
marketed. Recently this customer has attempted to generate polyclonal
antibodies with a commercial entity. The attempt was unsuccessful. The customer
believes that they will have better results working with a university core
facility.
They would like to use the same animals and immunization routine that yielded
enantiomer specific antibodies. The polyclonal antibodies work with WB of cell
lysates and bind free hapten. The antigen is a hapten conjugated to KLH using
glutaraldehyde. The customer will provide the antigen.
Here is the immunization scheme:
* Freund's Complete Adjuvant was used for the primary immunization, and
boosts consisted of antigen alone.
* 0.5 mL FCA + 500ug antigen in 0.5 mL
* 0.25 mL injected into 4 sites SQ
My core does not work with rabbits. I am looking for an experienced group that
can move forward with this project quickly and be prepared to boost and collect
sera monthly from animals for 10 months using the protocol above. The screening
of the sera would be done by the customer prior to purification. The
purification would be done in your facility. In the past, this group used
ammonium sulphate precipitation methods. They are amenable to trying Protein
A/G columns.
Please let me know if you are interested in taking on this project.
Best regards,
Angel
Edith "Angel" Sampson, Ph.D.
Monoclonal Antibody Scientific Director
UF ICBR
2033 Mowry Road, Gainesville, FL 32610
Biotech.ufl.edu<https://www.biotech.ufl.edu/> | Tel: 352.273.8039| Fax:
352.273.8070
Rest of post
[cid:image001.png@01D6C88C.546DFFC0]
This is a reminder to sign up for the webinar on Monday. Dr Brianne Barker
is one of the co-hosts of the popular podcast "This week in Virology" as
well as "Immune" so this should be really interesting.
Rest of post
---------- Forwarded message ---------
From: ken.schoppmann <email obscured>>
Date: Mon, Nov 9, 2020 at 1:20 PM
Subject: [ABRF Ab Forum] November webinar - SARS-CoV2 antibody responses:
knowns and unknowns - - 11/16; 11:00 am ET
To: <email obscured>>
SARS-CoV2 antibody responses: knowns and unknowns - - 11/16; 11:00 am ET
ABRF Antibody Technology Interest Network presentation
Join Professor Brianna Brewer, Drew University to discuss published data on
SARS-CoV2 antibody responses
Register here: https://lnkd.in/dXAP8Fz
โโ
View topic http://list.abrf.org/r/topic/T4OgqcoHhoYIikbtJELcL
Leave group <email obscured>?Subject=Unsubscribe
SARS-CoV2 antibody responses: knowns and unknowns - - 11/16; 11:00 am ET
ABRF Antibody Technology Interest Network presentation
Join Professor Brianna Brewer, Drew University to discuss published data on
SARS-CoV2 antibody responses
Register here: https://lnkd.in/dXAP8Fz
There's still to register for Monday's Antibody Technology Interest Network
presentation on
*Rapid Discovery of Functional Antibodies for SARS-CoV-2*
*Antibody Technology Interest Network Presentation:*
*Rapid Discovery of Functional Antibodies for SARS-CoV-2*
The COVID-19 pandemic highlights the importance of a flexible and rapid
response to real-time development of medical countermeasures for
life-threatening viral pathogens. Using human B cells from survivors are a
potential source of therapeutic antibodies, Dr. Carnahan will describe the
pandemic response platform developed and deployed at the Vanderbilt Vaccine
Center that has led to a large panel of anti-viral antibodies directed at
SARS-CoV-2, including several antibodies currently in advanced clinical
development.
Rest of post
*Monday, October 26, 2020 11:00 a.m.โ12:00 p.m. ET *Register here
<https://us02web.zoom.us/meeting/register/tZEscOiorTsvHNwYx2ZgZi_I9SH5l_OAD8Fj>
Register today to join us for this timely and informative presentation.
Speakers:
*Robert Carnahan, Ph.D.*
<https://www.vumc.org/crowe-lab/person/robert-carnahan-phd>
Associate Director, Vanderbilt Vaccine Center
Associate Professor, Pediatrics and Radiology and Radiologic Sciences
Vanderbilt University Medical Center
*David Blum, Ph.D.* <https://www.bmb.uga.edu/directory/people/david-blum>
Director, Bioexpression and Fermentation Facility
Director, Master of Biomanufacturing and Bioprocessing
University of Georgia
We have openings for speakers for our new antibody webinars in September
and November (dates flexible, but generally on Mondays at 11am EDT). Let
me know if you would like to give a talk or know somebody that could give a
talk for either of those months.
*[image: A screenshot of a cell phone Description automatically generated]*
*Monoclonal Antibodies from Bench to Bedside: Development in an Academic
Laboratory Core. Challenges*
*Monday, August 24, 2020 11:00 a.m.โ12:00 p.m. ET **Add to Calendar
<https://us02web.zoom.us/meeting/tZYoduihqDwqHd3R3FpdHkIUCBBxdSejoq2R/ics>*
*Register Here
<https://us02web.zoom.us/j/82511967079?pwd=SUo5WG1rWG9aNGd4ZHUrQWQ0WDhTdz09>*
Rest of post
This presentation will address different approaches that successfully
develop an anti-immune checkpoint antibody and other antibodies licensed to
Pharma companies and in ongoing clinical trials. Other approaches under
development will also be addressed.
Register today to join us for this timely and informative presentation.
Speakers:
*David Blum, Ph.D.*
Director, Bioexpression and Fermentation Facility
Director, Master of Biomanufacturing and Bioprocessing
University of Georgia
*Laura Bover, PhD*
Professor
Depts. of Genomic Medicine/Immunology
Director, Monoclonal Antibodies Core Facility
MD Anderson Cancer Center
University of Texas
Monday, August 24, 2020
11:00 a.m.โ12:00 p.m. ET
Register:
https://us02web.zoom.us/j/82511967079?pwd=SUo5WG1rWG9aNGd4ZHUrQWQ0WDhTdz09
This presentation will address different approaches that successfully develop
an anti-immune checkpoint antibody and other antibodies licensed to Pharma
companies and in ongoing clinical trials. Other approaches under development
will also be addressed.
Register today to join us for this timely and informative presentation.
Speakers:
David Blum, Ph.D.
Director, Bioexpression and Fermentation Facility
Director, Master of Biomanufacturing and Bioprocessing
University of Georgia
Laura Bover, PhD
Professor
Depts. of Genomic Medicine/Immunology
Director Monoclonal Antibodies Core Facility
Steering Committee of the Immunology Program GSBS (Graduate School of
Biomedical Sciences at Houston)
University of Texas M.D. Anderson Cancer Center
Yep
Once I hear from Ed.
Frances
ZRC 1563
Office 646-888-2354
Mobile 516-967-0656
๏ปฟOn 7/30/20, 9:38 AM, "Antibody Discussion Forum on behalf of Bover,Laura"
<email obscured> on behalf of <email obscured>> wrote:
Yes, please propose several times or later I send you my available ! Great!
Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Scientific Review Committee 2 (former CRC 2)
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://2/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>>
wrote:
WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
Ed and Laura
Can we set up a time learn about subtractive immunization early next
week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
โโ
View topic http://list.abrf.org/r/topic/2Ah9zjtxUijOERBGsq2mML
Leave group <email obscured>?Subject=Unsubscribe
*** Only open attachments or links from trusted senders. Report phishing to
<email obscured> ***
Rest of post
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
Sure thing
Frances
ZRC 1563
Office 646-888-2354
Mobile 516-967-0656
๏ปฟOn 7/30/20, 9:28 AM, "Antibody Discussion Forum on behalf of Christensen, Kurt
Richard" <email obscured> on behalf of <email obscured>> wrote:
Hi All,
I would love to attend this meeting too.
Thanks,
Kurt
Kurt Christensen
Lab Director
Protein and Monoclonal Antibody Production Core
Web Page:
https://www.bcm.edu/centers/cancer-center/research/shared-resources/antibody-based-proteomics/recombinant-protein-monoclonal-antibody
iLab Requests:
https://bcm.corefacilities.org/account/login
Office: 713-798-2325
Lab:713-798-2327
Email: <email obscured>
Baylor College of Medicine
Margaret M. Alkek Building for Biomedical Research, Room R551E, Mail Stop
BCM929
1 Baylor Plaza
Houston, Texas 77030
-----Original Message-----
From: Antibody Discussion Forum <email obscured>> On Behalf Of
<email obscured>
Sent: Thursday, July 30, 2020 7:53 AM
To: <email obscured>
Subject: [ABRF Ab Forum] Subtractive Immunization
Ed and Laura
Can we set up a time learn about subtractive immunization early next
week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.mskcc.org_research-2Dadvantage_core-2Dfacilities_monoclonal-2Dantibody-2Dcore-2Dfacility&d=DwIFaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=_dqqB8TU9vN7Hm15OCeZVQ&m=uYZyZT9rZlxPDXAgO4sY7s1f526UpbjrZqT6Io1lmzQ&s=T8dTpSgquLniYcOkZGwPG6ASMcxX3gvUzsVYpS6G9PA&e=
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.rockefeller.edu_monoclonal_&d=DwIFaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=_dqqB8TU9vN7Hm15OCeZVQ&m=uYZyZT9rZlxPDXAgO4sY7s1f526UpbjrZqT6Io1lmzQ&s=5iXjjoa8Sqa_UipQlx0eXQFCWCm4ZjJ_GTP2TTpw4eE&e=
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged,
confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this
message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_UGk03QWN9LUZhf49lemWo&d=DwIFaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=_dqqB8TU9vN7Hm15OCeZVQ&m=uYZyZT9rZlxPDXAgO4sY7s1f526UpbjrZqT6Io1lmzQ&s=HAQBEhvcDbZ2S297JhDlGaG43Sm9RNUCQm2cD4bzS2w&e=
Leave group <email obscured>?Subject=Unsubscribe
โโ
View topic http://list.abrf.org/r/topic/4pBtAV7OthreSZy0qLXj2D
Leave group <email obscured>?Subject=Unsubscribe
*** Only open attachments or links from trusted senders. Report phishing to
<email obscured> ***
Rest of post
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
Absolutely.
Frances
ZRC 1563
Office 646-888-2354
Mobile 516-967-0656
๏ปฟOn 7/30/20, 10:18 AM, "Antibody Discussion Forum on behalf of Angel Sampson"
<email obscured> on behalf of <email obscured>> wrote:
Dear all,
Is it possible for me to join the Zoom call to learn more about subtractive
immunization. I have been wanting to try it here at UF.
Kind regards,
Angel
Edith โAngelโ Sampson, Ph.D.
Monoclonal Antibody Scientific Director
UF ICBR
2033 Mowry Road, Gainesville, FL 32610
Biotech.ufl.edu | Tel: 352.273.8039| Fax: 352.273.8070
-----Original Message-----
From: Antibody Discussion Forum <email obscured>> On Behalf Of
Bover,Laura
Sent: Thursday, July 30, 2020 9:38 AM
To: <email obscured>
Subject: Re: [ABRF Ab Forum] [EXT] Subtractive Immunization
[External Email]
Yes, please propose several times or later I send you my available ! Great!
Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility University of Texas M.D.Anderson
Cancer Center Associate member of The University of Texas Graduate School of
Biomedical Sciences at Houston Member of the Scientific Review Committee 2
(former CRC 2) Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://2/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>>
wrote:
WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
Ed and Laura
Can we set up a time learn about subtractive immunization early next
week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
โโ
View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_2Ah9zjtxUijOERBGsq2mML&d=DwIFaQ&c=sJ6xIWYx-zLMB3EPkvcnVg&r=F6AO--4VYeLfDWXyalUQRQ&m=4iz1voPUApsW7XoXCeDbHEh3oVdv-G37GcJDCaOxbeA&s=hhSVRO1MsAk0UvQzbLnmFWUuZ96ZXVu_Rv1ybRTQqnM&e=
Leave group <email obscured>?Subject=Unsubscribe
โโ
View topic http://list.abrf.org/r/topic/5z9iGvqarHaHnBHHdaCRhs
Leave group <email obscured>?Subject=Unsubscribe
*** Only open attachments or links from trusted senders. Report phishing to
<email obscured> ***
Rest of post
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
Dear all,
Is it possible for me to join the Zoom call to learn more about subtractive
immunization. I have been wanting to try it here at UF.
Kind regards,
Angel
Edith โAngelโ Sampson, Ph.D.
Monoclonal Antibody Scientific Director
UF ICBR
2033 Mowry Road, Gainesville, FL 32610
Biotech.ufl.edu | Tel: 352.273.8039| Fax: 352.273.8070
Rest of post
-----Original Message-----
From: Antibody Discussion Forum <email obscured>> On Behalf Of
Bover,Laura
Sent: Thursday, July 30, 2020 9:38 AM
To: <email obscured>
Subject: Re: [ABRF Ab Forum] [EXT] Subtractive Immunization
[External Email]
Yes, please propose several times or later I send you my available ! Great!
Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility University of Texas M.D.Anderson
Cancer Center Associate member of The University of Texas Graduate School of
Biomedical Sciences at Houston Member of the Scientific Review Committee 2
(former CRC 2) Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://2/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>> wrote:
๏ปฟWARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
Ed and Laura
Can we set up a time learn about subtractive immunization early next week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
โโ
View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_2Ah9zjtxUijOERBGsq2mML&d=DwIFaQ&c=sJ6xIWYx-zLMB3EPkvcnVg&r=F6AO--4VYeLfDWXyalUQRQ&m=4iz1voPUApsW7XoXCeDbHEh3oVdv-G37GcJDCaOxbeA&s=hhSVRO1MsAk0UvQzbLnmFWUuZ96ZXVu_Rv1ybRTQqnM&e=
Leave group <email obscured>?Subject=Unsubscribe
Yes, please propose several times or later I send you my available ! Great!
Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Scientific Review Committee 2 (former CRC 2)
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://2/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>> wrote:
๏ปฟWARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
Ed and Laura
Can we set up a time learn about subtractive immunization early next week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
Rest of post
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
Hi All,
I would love to attend this meeting too.
Thanks,
Kurt
Kurt Christensen
Lab Director
Protein and Monoclonal Antibody Production Core
Web Page:
https://www.bcm.edu/centers/cancer-center/research/shared-resources/antibody-based-proteomics/recombinant-protein-monoclonal-antibody
iLab Requests:
https://bcm.corefacilities.org/account/login
Office: 713-798-2325
Lab:713-798-2327
Email: <email obscured>
Baylor College of Medicine
Margaret M. Alkek Building for Biomedical Research, Room R551E, Mail Stop
BCM929
1 Baylor Plaza
Houston, Texas 77030
Rest of post
-----Original Message-----
From: Antibody Discussion Forum <email obscured>> On Behalf Of
<email obscured>
Sent: Thursday, July 30, 2020 7:53 AM
To: <email obscured>
Subject: [ABRF Ab Forum] Subtractive Immunization
Ed and Laura
Can we set up a time learn about subtractive immunization early next week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.mskcc.org_research-2Dadvantage_core-2Dfacilities_monoclonal-2Dantibody-2Dcore-2Dfacility&d=DwIFaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=_dqqB8TU9vN7Hm15OCeZVQ&m=uYZyZT9rZlxPDXAgO4sY7s1f526UpbjrZqT6Io1lmzQ&s=T8dTpSgquLniYcOkZGwPG6ASMcxX3gvUzsVYpS6G9PA&e=
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.rockefeller.edu_monoclonal_&d=DwIFaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=_dqqB8TU9vN7Hm15OCeZVQ&m=uYZyZT9rZlxPDXAgO4sY7s1f526UpbjrZqT6Io1lmzQ&s=5iXjjoa8Sqa_UipQlx0eXQFCWCm4ZjJ_GTP2TTpw4eE&e=
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
โโ
View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_UGk03QWN9LUZhf49lemWo&d=DwIFaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=_dqqB8TU9vN7Hm15OCeZVQ&m=uYZyZT9rZlxPDXAgO4sY7s1f526UpbjrZqT6Io1lmzQ&s=HAQBEhvcDbZ2S297JhDlGaG43Sm9RNUCQm2cD4bzS2w&e=
Leave group <email obscured>?Subject=Unsubscribe
Ed and Laura
Can we set up a time learn about subtractive immunization early next week?
In the mean time Iโll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU website<https://www.rockefeller.edu/monoclonal/>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
Rest of post
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.